4//SEC Filing
Babu Yarlagadda S 4
Accession 0001127602-22-008780
CIK 0000882796other
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 4:24 PM ET
Size
4.7 KB
Accession
0001127602-22-008780
Insider Transaction Report
Form 4
Babu Yarlagadda S
VP Drug Discovery
Transactions
- Sale
Common Stock
2022-03-07$17.16/sh−20,000$343,200→ 230,056 total
Footnotes (1)
- [F1]The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $17.05 to $17.27. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001452635
Filing Metadata
- Form type
- 4
- Filed
- Mar 8, 7:00 PM ET
- Accepted
- Mar 9, 4:24 PM ET
- Size
- 4.7 KB